Risk Factors for Unplanned Early Implantable Port Catheter Removal in Adult Hematology Cancer Patients Receiving Chemotherapy: A Propensity Score Matching Study

References

• Niederhuber JE, Ensminger W, Gyves JW, et al. Totally implanted venous and arterial access system to replace external catheter in cancer treatment. Surgery. 1982;92:706–712.
   PubMed Web of Science ®Google Scholar
• Lebeaux D, Larroque B, Gellen-Dautremer J, et al. Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature. Medicine. 2012;91:309–318. doi:10.1097/MD.0b013e318275ffe1
   PubMed Web of Science ®Google Scholar
• Fischer L, Knebel P, Schroder S, et al. Reasons for explantation of totally implantable access ports: a multivariate analysis of 385 consecutive patients. Ann Surg Oncol. 2008;15:1124–1129. doi:10.1245/s10434-007-9783-z
   PubMed Web of Science ®Google Scholar
• Narducci F, Jean-Laurent M, Boulanger L, et al. Totally implantable venous access port systems and risk factors for complications: A one-year prospective study in a cancer centre. Eur J Surg Oncol. 2011;37:913–918. doi:10.1016/j.ejso.2011.06.016
   PubMed Web of Science ®Google Scholar
• Chen IC, Hsu C, Chen YC, et al. Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients. Ann Oncol. 2013;24:463–468. doi:10.1093/annonc/mds468
   PubMed Web of Science ®Google Scholar
• Zhang S, Kobayashi K, Faridnia M, Skummer P, Zhang D, Karmel MI. Clinical predictors of port infections in adult patients with hematologic malignancies. J Vasc Interv Radiol. 2018;29:1148–1155. doi:10.1016/j.jvir.2018.04.014
   PubMed Web of Science ®Google Scholar
• Bamba R, Lorenz JM, Lale AJ, Funaki BS, Zangan SM. Clinical predictors of port infections within the first 30 days of placement. J Vasc Interv Radiol. 2014;25:419–423. doi:10.1016/j.jvir.2013.11.038
   PubMed Web of Science ®Google Scholar
• Hoss DR, Bedros AA, Mesipam A, Criddle J, Smith JC. Severe neutropenia at the time of implantable subcutaneous chest port insertion is not a risk factor for port removal at a tertiary pediatric center. J Vasc Interv Radiol. 2017;28:398–402. doi:10.1016/j.jvir.2016.10.007
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40:373–383. doi:10.1016/0021-9681(87)90171-8
   PubMedGoogle Scholar
• Jager-Wittenaar H, Ottery FD. Assessing nutritional status in cancer: role of the patient-generated subjective global assessment. Curr Opin Clin Nutr Metab Care. 2017;20:322–329. doi:10.1097/MCO.0000000000000389
   PubMed Web of Science ®Google Scholar
• Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases society of America. Clin Infect Dis. 2009;49:1–45. doi:10.1086/599376
   PubMed Web of Science ®Google Scholar
• Groeger JS, Lucas AB, Thaler HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med. 1993;119:1168–1174. doi:10.7326/0003-4819-119-12-199312150-00003
   PubMed Web of Science ®Google Scholar
• Vidal M, Genillon JP, Forestier E, et al. Outcome of totally implantable venous-access port-related infections. Med Mal Infect. 2016;46:32–38. doi:10.1016/j.medmal.2015.12.006
   PubMed Web of Science ®Google Scholar
• Shaul DB, Scheer B, Rokhsar S, et al. Risk factors for early infection of central venous catheters in pediatric patients. J Am Coll Surg. 1998;186:654–658. doi:10.1016/S1072-7515(98)00096-9
   PubMed Web of Science ®Google Scholar
• Perez AW, Watchmaker JM, Brown DB, Banovac F. Association between periprocedural neutropenia and early infection-related chest port removal. Radiology. 2019;291:513–518. doi:10.1148/radiol.2019182175
   PubMed Web of Science ®Google Scholar
• VanHouwelingen LT, Veras LV, Lu M, et al. Neutropenia at the time of subcutaneous port insertion may not be a risk factor for early infectious complications in pediatric oncology patients. J Pediatr Surg. 2019;54:145–149. doi:10.1016/j.jpedsurg.2018.10.024
   PubMed Web of Science ®Google Scholar
• Carson JL, Stanworth SJ, Guyatt G, et al. Red blood cell transfusion: 2023 AABB international guidelines. JAMA. 2023. doi:10.1001/jama.2023.12914
   PubMedGoogle Scholar
• Adelborg K, Katalin V, Erzsébet Horváth P, Clouser M, Saad HA, Sørensen HT. Thrombocytopenia among patients with hematologic malignancies and solid tumors: risk and prognosis. Blood. 2021;138:3156. doi:10.1182/blood-2021-149668
   Google Scholar
• Keulers AR, Kiesow L, Mahnken AH. Port implantation in patients with severe thrombocytopenia is safe with interventional radiology. Cardiovasc Intervent Radiol. 2018;41:80–86. doi:10.1007/s00270-017-1794-y
   PubMed Web of Science ®Google Scholar
• Nitenberg G, Raynard B. Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol. 2000;34:137–168. doi:10.1016/S1040-8428(00)00048-2
   PubMed Web of Science ®Google Scholar
• Shike M. Nutrition therapy for the cancer patient. Hematol Oncol Clin North Am. 1996;10:221–234. doi:10.1016/S0889-8588(05)70336-1
   PubMed Web of Science ®Google Scholar
• Ravasco P. Nutrition in Cancer Patients. J Clin Med. 2019;8:1211. doi:10.3390/jcm8081211
   PubMed Web of Science ®Google Scholar
• Bauer J, Capra S, Ferguson M. Use of the scored patient-generated subjective global assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr. 2002;56:779–785. doi:10.1038/sj.ejcn.1601412
   PubMed Web of Science ®Google Scholar
• Benoist S, Brouquet A. Nutritional assessment and screening for malnutrition. J Visc Surg. 2015;152(Suppl 1):S3–7. doi:10.1016/S1878-7886(15)30003-5
   PubMedGoogle Scholar